In focus · trending topic

Medical Genetics and Genomics

1 stories · following the connections

Horizon Pharma plc to Present Data on RAVICTI® (glycerol phenylbutyrate) Oral Liquid for Urea Cycle Disorder Patients Aged Two Months to Two Years

By Nasdaq OMXMar 22, 2017, 1:00 PM UTC